Xu, S., Wang, W., Xu, C., Li, X., Ye, J., Zhu, Y., & Ge, T. (2019). ROS1-ADGRG6: A case report of a novel ROS1 oncogenic fusion variant in lung adenocarcinoma and the response to crizotinib. BMC Cancer.

Xu, Shuguang, Wenxian Wang, Chunwei Xu, Xingliang Li, Junhui Ye, Youcai Zhu, and Ting Ge. "ROS1-ADGRG6: A Case Report of a Novel ROS1 Oncogenic Fusion Variant in Lung Adenocarcinoma and the Response to Crizotinib." BMC Cancer 2019.

Xu, Shuguang, et al. "ROS1-ADGRG6: A Case Report of a Novel ROS1 Oncogenic Fusion Variant in Lung Adenocarcinoma and the Response to Crizotinib." BMC Cancer 2019.